J. Herbert Patterson

527 total citations
28 papers, 378 citations indexed

About

J. Herbert Patterson is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, J. Herbert Patterson has authored 28 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in J. Herbert Patterson's work include Heart Failure Treatment and Management (15 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiac pacing and defibrillation studies (5 papers). J. Herbert Patterson is often cited by papers focused on Heart Failure Treatment and Management (15 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiac pacing and defibrillation studies (5 papers). J. Herbert Patterson collaborates with scholars based in United States and Philippines. J. Herbert Patterson's co-authors include Kirkwood F. Adams, Melissa L. Ellis, Benoı̂t Mâsse, Mark M. Applefeld, Clinton N. Corder, Tess Lin, Mary Beth Blauwet, S. W. Clarke, S. Y. Tyree and Carla A. Sueta and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of Colloid and Interface Science.

In The Last Decade

J. Herbert Patterson

25 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Herbert Patterson United States 10 223 69 45 43 30 28 378
Prasart Laothavorn Thailand 8 176 0.8× 28 0.4× 40 0.9× 16 0.4× 44 1.5× 11 349
Jenny Wei United States 3 146 0.7× 44 0.6× 45 1.0× 51 1.2× 31 1.0× 7 366
Maria Grazia Bendini Italy 10 263 1.2× 43 0.6× 27 0.6× 23 0.5× 55 1.8× 27 418
Massimo Leggio Italy 11 293 1.3× 46 0.7× 30 0.7× 23 0.5× 60 2.0× 34 453
F. Schönau Jørgensen Denmark 12 87 0.4× 63 0.9× 20 0.4× 55 1.3× 51 1.7× 33 418
Monique Verschuren Netherlands 10 316 1.4× 25 0.4× 27 0.6× 20 0.5× 33 1.1× 12 572
Elif Arı Türkiye 13 72 0.3× 53 0.8× 93 2.1× 61 1.4× 99 3.3× 51 478
Andrew Rashkow United States 7 324 1.5× 77 1.1× 23 0.5× 13 0.3× 39 1.3× 11 437
Woo Jung Park South Korea 11 221 1.0× 102 1.5× 15 0.3× 61 1.4× 102 3.4× 29 454
Alireza Moaref Iran 12 179 0.8× 68 1.0× 28 0.6× 35 0.8× 98 3.3× 62 412

Countries citing papers authored by J. Herbert Patterson

Since Specialization
Citations

This map shows the geographic impact of J. Herbert Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Herbert Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Herbert Patterson more than expected).

Fields of papers citing papers by J. Herbert Patterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Herbert Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Herbert Patterson. The network helps show where J. Herbert Patterson may publish in the future.

Co-authorship network of co-authors of J. Herbert Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of J. Herbert Patterson. A scholar is included among the top collaborators of J. Herbert Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Herbert Patterson. J. Herbert Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patterson, J. Herbert, et al.. (2024). Low-Grade Glioma Clinical Trials in the United States: A Systematic Review. Life. 14(9). 1133–1133.
2.
Patterson, J. Herbert, et al.. (2024). A Cross-Sectional Analysis of Interventional Clinical Trials in High-Grade Glioma Therapy. Life. 14(8). 926–926. 2 indexed citations
3.
Greene, Stephen J., Gregg C. Fonarow, Adam D. DeVore, et al.. (2019). LONGITUDINAL CHANGES IN MEDICATION DOSING AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: FROM THE CHAMP-HF REGISTRY. Journal of the American College of Cardiology. 73(9). 707–707. 1 indexed citations
4.
Khariton, Yevgeniy, Michael E. Nassif, Laine Thomas, et al.. (2018). Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure. JACC Heart Failure. 6(6). 465–473. 73 indexed citations
5.
Khariton, Yevgeniy, Michael E. Nassif, Laine Thomas, et al.. (2017). Abstract 19403: Gender and Socioeconomic Disparities With Health Status in Outpatients With Heart Failure: Insights From the CHAMP-HF Registry. Circulation. 1 indexed citations
6.
Heywood, J. Thomas, et al.. (2015). Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials. Expert Review of Cardiovascular Therapy. 13(7). 743–751. 5 indexed citations
7.
Lin, Tess, Kirkwood F. Adams, & J. Herbert Patterson. (2014). Potential Roles of Vaptans in Heart Failure. Heart Failure Clinics. 10(4). 607–620. 6 indexed citations
8.
Adams, Kirkwood F., et al.. (2009). Biomarker guided therapy for heart failure: focus on natriuretic peptides. Heart Failure Reviews. 15(4). 351–370. 16 indexed citations
9.
Wagoner, Lynne E., Javed Butler, Ron M. Oren, et al.. (2004). 842-5 Anemia is common in patients with heart failure seen in specialty and community cardiology clinics: Results from the STAMINA: HFP registry (study of anemia in a heart failure population). Journal of the American College of Cardiology. 43(5). A217–A217. 6 indexed citations
10.
Ng, Tien M. H., Patricia Howard, Craig R. Lee, et al.. (2004). High‐Impact Articles Related to the Pharmacotherapeutic Management of Systolic Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(11). 1594–1633. 8 indexed citations
11.
Adams, Kirkwood F., J. Herbert Patterson, Wendy A. Gattis, et al.. (2003). Favorable effects of digoxin on mortality and morbidity in patients with class IV congestive heart failure due to systolic dysfunction: Retrospective analysis of the DIG study. Journal of the American College of Cardiology. 41(6). 164–164. 1 indexed citations
12.
Patterson, J. Herbert, Wendy A. Gattis, Jalal K. Ghali, et al.. (2003). Risk of death in patients with preserved systolic function: retrospective analysis of the digitalis investigational group (DIG) trial. Journal of Cardiac Failure. 9(5). S85–S85.
13.
Williamson, Kristin & J. Herbert Patterson. (1997). Is There an Expanded Role for Digoxin in Patients with Heart Failure and Sinus Rhythm? A Protagonist Viewpoint. Annals of Pharmacotherapy. 31(7-8). 888–892. 5 indexed citations
14.
Adams, Kirkwood F., Melissa L. Ellis, Kristin Williamson, & J. Herbert Patterson. (1997). The AHCPR Clinical Practice Guideline for Heart Failure Revisited. Annals of Pharmacotherapy. 31(10). 1197–1204. 8 indexed citations
15.
Martin, David E., et al.. (1996). Effects of Ofloxacin on the Pharmacokinetics and Pharmacodynamics of Procainamide. The Journal of Clinical Pharmacology. 36(1). 85–91. 16 indexed citations
16.
Patterson, J. Herbert, et al.. (1996). The Effects of Epoprostenol on Drug Disposition II: A Pilot Study of the Pharmacokinetics of Furosemide with and without Epoprostenol in Patients with Congestive Heart Failure. The Journal of Clinical Pharmacology. 36(3). 257–264. 8 indexed citations
17.
Ellis, Melissa L. & J. Herbert Patterson. (1996). A New Class of Antihypertensive Therapy: Angiotensin II Receptor Antagonists. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(5). 849–860. 31 indexed citations
18.
Sueta, Carla A., S. W. Clarke, Mary Beth Blauwet, et al.. (1994). Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure.. Circulation. 89(2). 660–666. 47 indexed citations
19.
Patterson, J. Herbert & Kirkwood F. Adams. (1993). Pathophysiology of Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(5P2). 73S–81S. 18 indexed citations
20.
Powell, J. Robert, James R. Foster, J. Herbert Patterson, Robert E. Cross, & William A. Wargin. (1986). Effect of duration of lidocaine infusion and route of cimetidine administration on lidocaine pharmacokinetics.. PubMed. 5(12). 993–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026